FDA Approves Drug Formulated for Kids With Rare Brain Tumors
FDA Approves Drug Formulated for Kids with Rare Brain Tumors
Filed under: Drug Rehab Centers District of Columbia
WASHINGTON, D.C. (8/30/12) – The U.S. Food and Drug Administration today approved Afinitor Disperz (everolimus tablets for oral suspension), a new pediatric… Continue reading
NY AG: Janssen Pays $181M Over Drug Marketing
NY AG: Janssen pays 1M over drug marketing
Filed under: Drug Abuse District of Columbia
Janssen Pharmaceuticals Inc. and parent company Johnson & Johnson on Thursday announced a $ 181 million settlement with 36 states and the District of Columbia… Continue reading
Monmouth, Middlesex Get Federal Grants for Substance Abuse Prevention
Monmouth, Middlesex Get Federal Grants For Substance Abuse Prevention
Filed under: District of Columbia Drug Abuse
Since 1998, ONDCP has awarded more than 2,000 Drug-Free Communities grants to local communities in all 50 states, the District of Columbia, Puerto Rico,… Continue reading
Hospitals Morphing Into Payers Now Motivated to Manage Cost and Care
Hospitals morphing into payers now motivated to manage cost and care
Filed under: District of Columbia Drug Rehabs
Electronic medical records and a wealth of health databases that did not exist during the first wave of managed care can now… Continue reading
Washington Area Business Diary for Week of Sept. 10
Washington area business diary for week of Sept. 10
Filed under: District of Columbia Drug Rehab Centers
Baltimore-based investment management company T. Rowe Price said it has moved its investor center in the District from 17th Street NW to the… Continue reading
J&J's Janssen Unit Announces $181 Mln Settlement in Deceptive Marketing Case
J&J's Janssen Unit Announces 1 Mln Settlement In Deceptive Marketing Case
Filed under: District of Columbia Drug Use
The company will pay about $ 181 million, an amount which has been previously accrued, as part of a consent decree to… Continue reading